AbbVie: Leerink Partners raises target price to $325 from $279
ABBV•Leerink Partners raised its target price for AbbVie to $325 from $279.
Related News
Australia's Emperor Energy gains on securing drilling contract for Victoria project
VAL•
FTI Consulting names Daniel Heywood senior managing director in Brisbane
FCN•
Hershey: Stephens cuts target price to $200 from $210
HSY•
Encompass Health Corporation: Mizuho raises target price to $155 from $140
EHC•
HDFC Bank business banking group head Sanjay D'Souza retires
HDB•